bioAffinity Technologies, Inc. (BIAF)
Nasdaq: BIAF · CIK 0001712762 · United States
Every official bioAffinity Technologies, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open BIAF filings
bioAffinity Technologies, Inc. documents
- bioAffinity Technologies, Inc. 10-K 2026BIAF 10-K 2026: annual report for fiscal 2026
- bioAffinity Technologies, Inc. 10-K 2025BIAF 10-K 2025: annual report for fiscal 2025
- bioAffinity Technologies, Inc. 10-K 2024BIAF 10-K 2024: annual report for fiscal 2024
- bioAffinity Technologies, Inc. 10-K 2023BIAF 10-K 2023: annual report for fiscal 2023
- bioAffinity Technologies, Inc. 10-K 2022BIAF 10-K 2022: annual report for fiscal 2022
- bioAffinity Technologies, Inc. 10-Q 2026BIAF 10-Q 2026: quarterly report for fiscal 2026
- bioAffinity Technologies, Inc. 10-Q 2025BIAF 10-Q 2025: quarterly report for fiscal 2025
- bioAffinity Technologies, Inc. 10-Q 2024BIAF 10-Q 2024: quarterly report for fiscal 2024
- bioAffinity Technologies, Inc. 10-Q 2023BIAF 10-Q 2023: quarterly report for fiscal 2023
- bioAffinity Technologies, Inc. 10-Q 2022BIAF 10-Q 2022: quarterly report for fiscal 2022
- bioAffinity Technologies, Inc. 8-K 2026BIAF 8-K 2026: current report for fiscal 2026
- bioAffinity Technologies, Inc. 8-K 2025BIAF 8-K 2025: current report for fiscal 2025
- bioAffinity Technologies, Inc. 8-K 2024BIAF 8-K 2024: current report for fiscal 2024
- bioAffinity Technologies, Inc. 8-K 2023BIAF 8-K 2023: current report for fiscal 2023
- bioAffinity Technologies, Inc. 8-K 2022BIAF 8-K 2022: current report for fiscal 2022
- bioAffinity Technologies, Inc. DEF 14A 2026BIAF DEF 14A 2026: proxy statement for fiscal 2026
- bioAffinity Technologies, Inc. DEF 14A 2025BIAF DEF 14A 2025: proxy statement for fiscal 2025
- bioAffinity Technologies, Inc. DEF 14A 2024BIAF DEF 14A 2024: proxy statement for fiscal 2024
- bioAffinity Technologies, Inc. DEF 14A 2023BIAF DEF 14A 2023: proxy statement for fiscal 2023
- bioAffinity Technologies, Inc. DEF 14A 2022BIAF DEF 14A 2022: proxy statement for fiscal 2022
- bioAffinity Technologies, Inc. Form 4 2026BIAF Form 4 2026: insider trading filing for fiscal 2026
- bioAffinity Technologies, Inc. Form 4 2025BIAF Form 4 2025: insider trading filing for fiscal 2025
- bioAffinity Technologies, Inc. Form 4 2024BIAF Form 4 2024: insider trading filing for fiscal 2024
- bioAffinity Technologies, Inc. Form 4 2023BIAF Form 4 2023: insider trading filing for fiscal 2023
- bioAffinity Technologies, Inc. Form 4 2022BIAF Form 4 2022: insider trading filing for fiscal 2022
- bioAffinity Technologies, Inc. S-1 2026BIAF S-1 2026: registration statement for fiscal 2026
- bioAffinity Technologies, Inc. S-1 2025BIAF S-1 2025: registration statement for fiscal 2025
- bioAffinity Technologies, Inc. S-1 2024BIAF S-1 2024: registration statement for fiscal 2024
- bioAffinity Technologies, Inc. S-1 2023BIAF S-1 2023: registration statement for fiscal 2023
- bioAffinity Technologies, Inc. S-1 2022BIAF S-1 2022: registration statement for fiscal 2022
- bioAffinity Technologies, Inc. 13F 2026BIAF 13F 2026: institutional holdings for fiscal 2026
- bioAffinity Technologies, Inc. 13F 2025BIAF 13F 2025: institutional holdings for fiscal 2025
- bioAffinity Technologies, Inc. 13F 2024BIAF 13F 2024: institutional holdings for fiscal 2024
- bioAffinity Technologies, Inc. 13F 2023BIAF 13F 2023: institutional holdings for fiscal 2023
- bioAffinity Technologies, Inc. 13F 2022BIAF 13F 2022: institutional holdings for fiscal 2022
More companies